Nxera Pharma Co., Ltd. (4565.T)

JPY 1056.0

(1.15%)

Revenue Summary of Nxera Pharma Co., Ltd.

  • Nxera Pharma Co., Ltd.'s latest annual revenue in 2023 was 12.76 Billion JPY , down -18.0% from previous year.
  • Nxera Pharma Co., Ltd.'s latest quarterly revenue in 2024 Q3 was 9.26 Billion JPY , up 14.23% from previous quarter.
  • Nxera Pharma Co., Ltd. reported a annual revenue of 15.56 Billion JPY in annual revenue 2022, down -12.1% from previous year.
  • Nxera Pharma Co., Ltd. reported a annual revenue of 17.71 Billion JPY in annual revenue 2021, up 100.32% from previous year.
  • Nxera Pharma Co., Ltd. reported a quarterly revenue of 9.26 Billion JPY for 2024 Q3, up 14.23% from previous quarter.
  • Nxera Pharma Co., Ltd. reported a quarterly revenue of 4.61 Billion JPY for 2024 Q1, down -36.77% from previous quarter.

Annual Revenue Chart of Nxera Pharma Co., Ltd. (2023 - 2004)

Historical Annual Revenue of Nxera Pharma Co., Ltd. (2023 - 2004)

Year Revenue Revenue Growth
2023 12.76 Billion JPY -18.0%
2022 15.56 Billion JPY -12.1%
2021 17.71 Billion JPY 100.32%
2020 8.84 Billion JPY -9.09%
2019 9.72 Billion JPY 153.99%
2018 3.82 Billion JPY -44.94%
2017 6.95 Billion JPY -63.2%
2016 18.9 Billion JPY 131.89%
2015 8.15 Billion JPY 122.02%
2014 3.67 Billion JPY 77.37%
2013 2.06 Billion JPY 5.66%
2012 1.95 Billion JPY 127.15%
2011 862.41 Million JPY 20.35%
2010 716.57 Million JPY -22.08%
2009 919.68 Million JPY 501.45%
2008 152.91 Million JPY -78.44%
2007 709.12 Million JPY -4.14%
2006 739.77 Million JPY 78.04%
2005 415.5 Million JPY 70.01%
2004 244.39 Million JPY 0.0%

Peer Revenue Comparison of Nxera Pharma Co., Ltd.

Name Revenue Revenue Difference
KOHJIN BIO CO LTD 4.77 Billion JPY -167.626%
PRISM BioLab Co.,LTD 112.92 Million JPY -11204.748%
GNI Group Ltd. 26.01 Billion JPY 50.92%
Linical Co., Ltd. 12.3 Billion JPY -3.722%
Trans Genic Inc. 13.08 Billion JPY 2.426%
MEDINET Co., Ltd. 661.54 Million JPY -1829.731%
Soiken Holdings Inc. 5.15 Billion JPY -147.477%
Cytori Cell Research Institute, Inc. 1.56 Billion JPY -718.13%
AnGes, Inc. 152.98 Million JPY -8244.609%
OncoTherapy Science, Inc. 610.11 Million JPY -1992.382%
Immuno-Biological Laboratories Co., Ltd. 816.7 Million JPY -1463.118%
NanoCarrier Co., Ltd. 135.5 Million JPY -9320.846%
Carna Biosciences, Inc. 1.62 Billion JPY -685.17%
CanBas Co., Ltd. - JPY -Infinity%
D. Western Therapeutics Institute, Inc. 428.36 Million JPY -2880.176%
RaQualia Pharma Inc. 1.9 Billion JPY -571.47%
Chiome Bioscience Inc. 682.46 Million JPY -1770.575%
Kidswell Bio Corporation 2.43 Billion JPY -425.083%
PeptiDream Inc. 28.71 Billion JPY 55.538%
Oncolys BioPharma Inc. 63.03 Million JPY -20151.277%
Ribomic Inc. - JPY -Infinity%
SanBio Company Limited - JPY -Infinity%
Healios K.K. 121 Million JPY -10450.413%
BrightPath Biotherapeutics Co., Ltd. 72 Thousand JPY -17730455.556%
Kubota Pharmaceutical Holdings Co., Ltd. 39.88 Million JPY -31905.415%
Delta-Fly Pharma, Inc. - JPY -Infinity%
StemRIM - JPY -Infinity%
CellSource Co., Ltd. 4.51 Billion JPY -183.026%
FunPep Company Limited 530 Thousand JPY -2408579.245%
Kringle Pharma, Inc. 69.25 Million JPY -18334.657%
Stella Pharma Corporation 269.49 Million JPY -4637.078%
TMS Co., Ltd. - JPY -Infinity%
Noile-Immune Biotech Inc. 316.81 Million JPY -3929.443%
Cuorips Inc. 23.1 Million JPY -55159.285%
K Pharma,Inc. 1 Billion JPY -1176.6%
Takara Bio Inc. 43.5 Billion JPY 70.656%
ReproCELL Incorporated 2.42 Billion JPY -426.039%
PhoenixBio Co., Ltd. 1.71 Billion JPY -644.234%
StemCell Institute Inc. 2.48 Billion JPY -414.511%
Japan Tissue Engineering Co., Ltd. 2.51 Billion JPY -407.758%
CellSeed Inc. 190.13 Million JPY -6614.212%